These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34966964)

  • 21. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.
    Lind SE; McDonagh JR; Smith CJ
    Blood; 1993 Sep; 82(5):1522-31. PubMed ID: 8364203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oxidants on proteases of the fibrinolytic system: possible role for methionine residues in the interaction between tissue type plasminogen activator and fibrin.
    Stief TW; Martín E; Jimenez J; Digón J; Rodriguez JM
    Thromb Res; 1991 Feb; 61(3):191-200. PubMed ID: 1827545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues.
    Parry MA; Zhang XC; Bode I
    Trends Biochem Sci; 2000 Feb; 25(2):53-9. PubMed ID: 10664583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen-dependent proteolytic activity in Bifidobacterium lactis.
    Candela M; Miccoli G; Bergmann S; Turroni S; Vitali B; Hammerschmidt S; Brigidi P
    Microbiology (Reading); 2008 Aug; 154(Pt 8):2457-2462. PubMed ID: 18667578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen.
    Takayasu R; Hasumi K; Shinohara C; Endo A
    FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
    Foley JH; Cook PF; Nesheim ME
    J Biol Chem; 2011 Jun; 286(22):19280-6. PubMed ID: 21467042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemical processing of fibrinogen modified-graphite surfaces: effect on plasmin generation from adsorbed plasminogen.
    Alfonsi-Hourdin S; Longchamp S; Gallet O; Nigretto JM
    Biomaterials; 2006 Jan; 27(1):52-60. PubMed ID: 16029886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interaction of heavy and light chains of plasmin with fibrinogen E and D fragments].
    Kudinov SA; Lezhen TI
    Biokhimiia; 1984 Dec; 49(12):2003-7. PubMed ID: 6240993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation.
    Bobbink IW; Tekelenburg WL; Sixma JJ; de Boer HC; Banga JD; de Groot PG
    Biochem Biophys Res Commun; 1997 Nov; 240(3):595-601. PubMed ID: 9398610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.
    Butera D; Wind T; Lay AJ; Beck J; Castellino FJ; Hogg PJ
    J Biol Chem; 2014 Jan; 289(5):2992-3000. PubMed ID: 24338014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypochlorite-Induced Damage of Plasminogen Molecules: Structural-Functional Disturbance.
    Vasilyeva AD; Yurina LV; Shchegolikhin AN; Bugrova AE; Konstantinova TS; Indeykina MI; Kononikhin AS; Nikolaev EN; Rosenfeld MA
    Dokl Biochem Biophys; 2019 Sep; 488(1):332-337. PubMed ID: 31768854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxynitrite and fibrinolytic system: the effect of peroxynitrite on plasmin activity.
    Nowak P; Kołodziejczyk J; Wachowicz B
    Mol Cell Biochem; 2004 Dec; 267(1-2):141-6. PubMed ID: 15663195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kringle domains and plasmin denaturation.
    Shi GY; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1991 Jul; 178(1):360-8. PubMed ID: 1829887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.